This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Glucagon and glucagon-like peptide-1 dual agonist therapy: A possible future towards fatty kidney disease.
European journal of clinical investigation, 55(1), e14330
Citation
Kanbay, Mehmet; Copur, Sidar; Guldan, Mustafa; Ozbek, Lasin; Mallamaci, Francesca; Zoccali, Carmine. (2025). Glucagon and glucagon-like peptide-1 dual agonist therapy: A possible future towards fatty kidney disease.. European journal of clinical investigation, 55(1), e14330. https://doi.org/10.1111/eci.14330